Related Experiment Video
Updated: Oct 26, 2025

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Junwei Xiang1,2, Zhengyan Zhang1,2, Hongyi Xie1,2
1Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzhou, China.
Abstract:
Farnesoid X receptor (FXR) is a nuclear receptor for bile acids (BAs) that is widely expressed in the intestine, liver and kidney. FXR has important regulatory impacts on a wide variety of metabolic pathways (such as glucose, lipid, and sterol metabolism) and has been recognized to ameliorate obesity, liver damage, cholestasis and chronic inflammatory diseases. The types of BAs are complex and diverse. BAs link the intestine with the liver through the enterohepatic circulation. BAs derivatives have entered clinical trials for liver disease. In addition to the liver, the intestine is also targeted by BAs. This article reviews the effects of different BAs on the intestinal tract through the enterohepatic circulation from the perspective of FXR, aiming to elucidate the effects of different BAs on the intestinal tract and lay a foundation for new treatment methods.
Insights
Farnesoid X receptor (FXR), activated by bile acids (BAs), influences gut health and metabolism. This review explores how different BAs impact the intestine via FXR, paving the way for novel therapeutic strategies.
Area of Science:
- Metabolic regulation
- Hepatology
- Gastroenterology
Background:
- Farnesoid X receptor (FXR) is a nuclear receptor activated by bile acids (BAs).
- FXR plays a crucial role in regulating glucose, lipid, and sterol metabolism.
- FXR activation is linked to improvements in obesity, liver damage, cholestasis, and inflammatory diseases.
Purpose of the Study:
- To review the effects of diverse bile acids on the intestinal tract.
- To examine these effects through the lens of the enterohepatic circulation and FXR signaling.
- To provide a foundation for developing new therapeutic approaches targeting intestinal BA metabolism.
Main Methods:
- Literature review focusing on bile acids and FXR.
- Analysis of the enterohepatic circulation's role in BA-gut interactions.
- Synthesis of current understanding of FXR's intestinal functions.
Main Results:
- Bile acids exert significant regulatory effects on the intestinal tract.
- FXR is a key mediator of these BA-induced intestinal effects.
- Diverse BA profiles influence distinct metabolic and inflammatory pathways within the intestine.
Conclusions:
- Bile acids and FXR signaling are critical regulators of intestinal homeostasis.
- Understanding BA-FXR interactions in the intestine opens avenues for treating metabolic and inflammatory conditions.
- Targeting intestinal FXR offers potential for novel therapeutic interventions.
Related Concept Videos
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Bile
Bile is released when dietary fats enter...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

